Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check3 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed. No changes to core content, pricing, stock availability, or time slots.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has been updated to include specific information about drug safety and counterfeit drugs, along with the addition of a facility name and location in St. Louis, Missouri. Notably, references to certain diseases have been removed, including Acute Graft Versus Host Disease and Acute Non Lymphoblastic Leukemia.SummaryDifference3%
- Check24 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.8%
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.8%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.